[Other] Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes

 Close Closed
danielgsfb Post time 2023-1-24 08:56:53 | Show all posts |Read mode
Reward10points

journal£ºDiabetes Care

Authors£ºEvangelos K. Oikonomou; Marc A. Suchard; Darren K. McGuire; Rohan Khera

Published date£º2022-4-1

DOI£º10.2337/dc21-1765

Article link£ºhttp://dx.doi.org/10.2337/dc21-1765

Article Source£ºAmerican Diabetes Association¡£


Remark£º
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    931

Latest Reply



Return to the list